PROTACs for BRDs proteins in cancer therapy: a review

por Wang, Chao, Zhang, Yujing, Yang, Shanbo, Chen, Wujun, Xing, Dongming
Publicado 2022

Recent advances in IAP-based PROTACs (SNIPERs) as potential therapeutic agents

por Wang, Chao, Zhang, Yujing, Shi, Lingyu, Yang, Shanbo, Chang, Jing, Zhong, Yingjie, Li, Qian, Xing, Dongming
Publicado 2022

Research progress on antitumor activity of XRP44X and analogues as microtubule targeting agents

por Wang, Chao, Shi, Lingyu, Yang, Shanbo, Chang, Jing, Liu, Wenjing, Zeng, Jun, Meng, Jingsen, Zhang, Renshuai, Xing, Dongming
Publicado 2023

The role of NPC1L1 in cancer

por Zhang, Renshuai, Zeng, Jun, Liu, Wenjing, Meng, Jingsen, Wang, Chao, Shi, Lingyu, Yang, Shanbo, Chang, Jing, Xing, Dongming
Publicado 2022

Recent Advances on the Role of ATGL in Cancer

por Zhang, Renshuai, Meng, Jingsen, Yang, Shanbo, Liu, Wenjing, Shi, Lingyu, Zeng, Jun, Chang, Jing, Liang, Bing, Liu, Ning, Xing, Dongming
Publicado 2022

Design, synthesis and biological evaluation of 9-aryl-5H-pyrido[4,3-b]indole derivatives as potential tubulin polymerization inhibitors

por Shi, Lingyu, Yang, Shanbo, Chang, Jing, Zhang, Yujing, Liu, Wenjing, Zeng, Jun, Meng, Jingsen, Zhang, Renshuai, Wang, Chao, Xing, Dongming
Publicado 2022

Advances in antitumor research of CA-4 analogs carrying quinoline scaffold

por Wang, Chao, Chang, Jing, Yang, Shanbo, Shi, Lingyu, Zhang, Yujing, Liu, Wenjing, Meng, Jingsen, Zeng, Jun, Zhang, Renshuai, Xing, Dongming
Publicado 2022

Inhibitory Effect of Isoliquiritigenin in Niemann-Pick C1-Like 1-Mediated Cholesterol Uptake

por Zeng, Jun, Liu, Wenjing, Liang, Bing, Shi, Lingyu, Yang, Shanbo, Meng, Jingsen, Chang, Jing, Hu, Xiaokun, Zhang, Renshuai, Xing, Dongming
Publicado 2022

Design, synthesis and biological evaluation of novel diarylpyridine derivatives as tubulin polymerisation inhibitors

por Yang, Shanbo, Wang, Chao, Shi, Lingyu, Chang, Jing, Zhang, Yujing, Meng, Jingsen, Liu, Wenjing, Zeng, Jun, Zhang, Renshuai, Shao, Yingchun, Xing, Dongming
Publicado 2022

First Discovery of Cholesterol-Lowering Activity of Parthenolide as NPC1L1 Inhibitor

por Liu, Wenjing, Liang, Bing, Zeng, Jun, Meng, Jingsen, Shi, Lingyu, Yang, Shanbo, Chang, Jing, Wang, Chao, Hu, Xiaokun, Wang, Xufu, Han, Na, Lu, Chenghui, Li, Jiao, Wang, Congcong, Li, Huanting, Zhang, Renshuai, Xing, Dongming
Publicado 2022